Skip to main content
SpringerLink
Log in

Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions

  • Published:
Amino Acids Aims and scope Submit manuscript

Summary.

Objectives. Human gliomas have a catastrophic prognosis with a median survival in the range of one year even after therapeutic treatment. Relatively high resistance towards apoptotic stimuli is the characteristic feature of malignant gliomas. Since cell cycle control has been shown to be the key mechanism controlling both apoptosis and proliferation, this study focuses on DNA damage analysis and protein expression patterns of essential cell cycle regulators P53 and P21waf1/cip1 in glioma under clinically relevant therapeutic conditions.

Material and methods. U87MG cell line, characterised by wild p53-phenotype relevant for the majority of primary malignant glioblastomas, was used. Glioma cells underwent either irradiation or temozolomide treatment alone, or combined radio/chemo treatment. DNA damage was analysed by the “Comet Assay”. Expression rates of target proteins were analysed using “Western-Blot” technique.

Results and conclusions. “Comet Assay” demonstrated extensive DNA damage caused by temozolomide treatment alone and in combination with irradiation, correlating well with the low survival rate observed under these treatment conditions. In contrast, irradiation alone resulted in a relatively low DNA damage, correlating well with a high survival rate and indicating a poor therapeutic efficiency of irradiation alone. Unusually low up-regulation of P53 and P21waf1/cip1 expression patterns was produced by the hereby tested stressful conditions. A deficit in cell cycle control might be the clue to the high resistance of malignant glioma cells to established therapeutic approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • I Ader C Delmas J Bonnet P Rochaix G Favre C Toulas E Cohen-Jonathan-Moyal (2003) ArticleTitleInhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts Oncogene 22 8861–8869 Occurrence Handle14654782 Occurrence Handle10.1038/sj.onc.1207095 Occurrence Handle1:CAS:528:DC%2BD3sXpsVGhtrg%3D

    Article  PubMed  CAS  Google Scholar 

  • M Bower ES Newlands NM Bleehen M Brada RJ Begent H Calvert I Colquhoun P Lewis MH Brampton (1997) ArticleTitleMulticentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma Cancer Chemother Pharmacol 40 484–488 Occurrence Handle9332462 Occurrence Handle10.1007/s002800050691 Occurrence Handle1:CAS:528:DyaK2sXmt1egsLo%3D

    Article  PubMed  CAS  Google Scholar 

  • BD Chang K Watanabe EV Broude J Fang JC Poole TV Kalinichenko IB Roninson (2000) ArticleTitleEffects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases Proc Natl Acad Sci USA 97 4291–4296 Occurrence Handle10760295 Occurrence Handle10.1073/pnas.97.8.4291 Occurrence Handle1:CAS:528:DC%2BD3cXislSnsrs%3D

    Article  PubMed  CAS  Google Scholar 

  • J Chen T Willingham M Shuford D Bruce E Rushing Y Smith PD Nisen (1996) ArticleTitleEffects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells Oncogene 13 1395–1403 Occurrence Handle8875977 Occurrence Handle1:CAS:528:DyaK28XmsFGmsbc%3D

    PubMed  CAS  Google Scholar 

  • BJ Denny RT Wheelhouse MF Stevens LL Tsang JA Slack (1994) ArticleTitleNMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA Biochemistry 33 9045–9051 Occurrence Handle8049205 Occurrence Handle10.1021/bi00197a003 Occurrence Handle1:CAS:528:DyaK2cXkvF2hsbs%3D

    Article  PubMed  CAS  Google Scholar 

  • O Golubnitschaja H Moenkemann K Kim MS Mozaffari (2003) ArticleTitleDNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in taurine-deficient cardiomyocytes Biochem Pharmacol 66 511–517 Occurrence Handle12907251 Occurrence Handle10.1016/S0006-2952(03)00285-5 Occurrence Handle1:CAS:528:DC%2BD3sXlvFygt7g%3D

    Article  PubMed  CAS  Google Scholar 

  • O Golubnitschaja-Labudova R Liu C Decker P Zhu IO Haefliger J Flammer (2000) ArticleTitleAltered gene expression in lymphocytes of patients with normal-tension glaucoma Curr Eye Res 21 867–876 Occurrence Handle11262608 Occurrence Handle10.1076/ceyr.21.5.867.5534 Occurrence Handle1:STN:280:DC%2BD3M7mt1Kitw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • B Hegedus J Zach A Czirok J Lovey T Vicsek (2004) ArticleTitleIrradiation and Taxol treatment result in non-monotonous, dose-dependent changes in the motility of glioblastoma cells J Neurooncol 67 147–157 Occurrence Handle15072462 Occurrence Handle10.1023/B:NEON.0000021826.73020.f3

    Article  PubMed  Google Scholar 

  • M Hermisson A Klumpp W Wick J Wischhusen G Nagel W Roos B Kaina M Weller (2006) ArticleTitleO6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells J Neurochem 96 766–776 Occurrence Handle16405512 Occurrence Handle10.1111/j.1471-4159.2005.03583.x Occurrence Handle1:CAS:528:DC%2BD28XjsFCnu78%3D

    Article  PubMed  CAS  Google Scholar 

  • Y Hirose MS Berger RO Pieper (2001) ArticleTitlep53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells Cancer Res 61 1957–1963 Occurrence Handle11280752 Occurrence Handle1:CAS:528:DC%2BD3MXit1Ogsrk%3D

    PubMed  CAS  Google Scholar 

  • H Horiguchi T Sano T Hirose (2001) ArticleTitleTP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization Pathol Int 51 187–192 Occurrence Handle11328534 Occurrence Handle10.1046/j.1440-1827.2001.01186.x Occurrence Handle1:CAS:528:DC%2BD3MXjvVCltLk%3D

    Article  PubMed  CAS  Google Scholar 

  • T Kokunai I Izawa N Tamaki (1998) ArticleTitleOverexpression of p21WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line Int J Cancer 75 643–648 Occurrence Handle9466669 Occurrence Handle10.1002/(SICI)1097-0215(19980209)75:4<643::AID-IJC24>3.0.CO;2-8 Occurrence Handle1:CAS:528:DyaK1cXhtV2ks7c%3D

    Article  PubMed  CAS  Google Scholar 

  • S Kominsky HM Johnson G Bryan T Tanabe AC Hobeika PS Subramaniam B Torres (1998) ArticleTitleIFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1 Oncogene 17 2973–2979 Occurrence Handle9881699 Occurrence Handle10.1038/sj.onc.1202217 Occurrence Handle1:CAS:528:DyaK1MXjtleisQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Lemay KA Wood (1999) ArticleTitleDetection of DNA damage and identification of UV-induced photoproducts using the CometAssay kit Biotechniques 27 846–851 Occurrence Handle10524327 Occurrence Handle1:CAS:528:DyaK1MXmslCit74%3D

    PubMed  CAS  Google Scholar 

  • RS Malyapa C Bi EW Ahern Roti JL Roti (1998) ArticleTitleDetection of DNA damage by the alkaline comet assay after exposure to low-dose gamma radiation Radiat Res 149 396–400 Occurrence Handle9525505 Occurrence Handle10.2307/3579703 Occurrence Handle1:CAS:528:DyaK1cXit1eqs7s%3D

    Article  PubMed  CAS  Google Scholar 

  • H Moenkemann J Flammer K Wunderlich W Breipohl HH Schild O Golubnitschaja (2005) ArticleTitleIncreased DNA breaks and up-regulation of both G(1) and G(2) checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in circulating leukocytes of glaucoma patients and vasospastic individuals Amino Acids 28 199–205 Occurrence Handle15723242 Occurrence Handle10.1007/s00726-005-0169-x Occurrence Handle1:CAS:528:DC%2BD2MXitlCmtLg%3D

    Article  PubMed  CAS  Google Scholar 

  • M Muller (2000) ArticleTitleTranscriptional control of hepatocanalicular transporter gene expression Semin Liver Dis 20 323–337 Occurrence Handle11076399 Occurrence Handle10.1055/s-2000-9387 Occurrence Handle1:CAS:528:DC%2BD3cXotVOmurg%3D

    Article  PubMed  CAS  Google Scholar 

  • CL Nutt M Noble AF Chambers JG Cairncross (2000) ArticleTitleDifferential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy Cancer Res 60 4812–4818 Occurrence Handle10987291 Occurrence Handle1:CAS:528:DC%2BD3cXmsFWhs7s%3D

    PubMed  CAS  Google Scholar 

  • H Ohgaki P Dessen B Jourde S Horstmann T Nishikawa PL Di Patre C Burkhard D Schuler NM Probst-Hensch PC Maiorka N Baeza P Pisani Y Yonekawa MG Yaşargil UM Lutolf P Kleihues (2004) ArticleTitleGenetic pathways to glioblastoma: a population-based study Cancer Res 64 6892–6899 Occurrence Handle15466178 Occurrence Handle10.1158/0008-5472.CAN-04-1337 Occurrence Handle1:CAS:528:DC%2BD2cXotFalsrc%3D

    Article  PubMed  CAS  Google Scholar 

  • D Osoba M Brada WK Yung M Prados (2000) ArticleTitleHealth-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme J Clin Oncol 18 1481–1491 Occurrence Handle10735896 Occurrence Handle1:CAS:528:DC%2BD3cXivVeis74%3D

    PubMed  CAS  Google Scholar 

  • O Ostling KJ Johanson (1984) ArticleTitleMicroelectrophoretic study of radiation-induced DNA damages in individual mammalian cells Biochem Biophys Res Commun 123 291–298 Occurrence Handle6477583 Occurrence Handle1:CAS:528:DyaL2cXlsVKqs7w%3D Occurrence Handle10.1016/0006-291X(84)90411-X

    Article  PubMed  CAS  Google Scholar 

  • F Paulsen W Hoffmann G Becker C Belka M Weinmann J Classen RD Kortmann M Bamberg (1999) ArticleTitleChemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide J Cancer Res Clin Oncol 125 411–418 Occurrence Handle10394962 Occurrence Handle10.1007/s004320050295 Occurrence Handle1:CAS:528:DyaK1MXktVSqsLo%3D

    Article  PubMed  CAS  Google Scholar 

  • R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff (2005) ArticleTitleEuropean Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987–996 Occurrence Handle15758009 Occurrence Handle10.1056/NEJMoa043330 Occurrence Handle1:CAS:528:DC%2BD2MXit1Wksbk%3D

    Article  PubMed  CAS  Google Scholar 

  • L Tentori I Portarena F Torino M Scerrati P Navarra G Graziani (2002) ArticleTitlePoly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells Glia 40 44–54 Occurrence Handle12237842 Occurrence Handle10.1002/glia.10113

    Article  PubMed  Google Scholar 

  • D Trog H Moenkemann N Haertel H Schuller O Golubnitschaja (2005) ArticleTitleExpression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment Amino Acids 28 213–219 Occurrence Handle15723240 Occurrence Handle10.1007/s00726-005-0171-3 Occurrence Handle1:CAS:528:DC%2BD2MXitlCmtLY%3D

    Article  PubMed  CAS  Google Scholar 

  • D Trog M Fountoulakis A Friedlein O Golubnitschaja (2006a) ArticleTitleIs current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions Proteomics 6 2924–2930 Occurrence Handle10.1002/pmic.200500587 Occurrence Handle1:CAS:528:DC%2BD28XltF2itb0%3D

    Article  CAS  Google Scholar 

  • D Trog K Yeghiazaryan M Fountoulakis A Friedlein H Moenkemann N Haertel H Schueller W Breipohl H Schild D Leppert O Golubnitschaja (2006b) ArticleTitlePro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells Eur J Pharmacol 542 8–15 Occurrence Handle10.1016/j.ejphar.2006.05.026 Occurrence Handle1:CAS:528:DC%2BD28XntlWmtLo%3D

    Article  CAS  Google Scholar 

  • SR Wedge ES Newlands (1996) ArticleTitleO6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU Br J Cancer 73 1049–1052 Occurrence Handle8624262 Occurrence Handle1:CAS:528:DyaK28XjtlSiur4%3D

    PubMed  CAS  Google Scholar 

  • C Wild-Bode M Weller A Rimner J Dichgans W Wick (2001) ArticleTitleSublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma Cancer Res 61 2744–2750 Occurrence Handle11289157 Occurrence Handle1:CAS:528:DC%2BD3MXisVSksbs%3D

    PubMed  CAS  Google Scholar 

  • WK Yung MD Prados R Yaya-Tur SS Rosenfeld M Brada HS Friedman R Albright J Olson SM Chang AM O’Neill AH Friedman J Bruner N Yue M Dugan S Zaknoen VA Levin (1999) ArticleTitleMulticenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group J Clin Oncol 17 2762–2771 Occurrence Handle10561351 Occurrence Handle1:CAS:528:DyaK1MXmtlWru7s%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Friedrich-Wilhelms-University of Bonn, Bonn, Germany

    D. Trog, H. Moenkemann, H. Schueller, H. Schild & O. Golubnitschaja

  2. Department of Ophthalmology, Friedrich-Wilhelms-University of Bonn, Bonn, Germany

    W. Breipohl

Authors
  1. D. Trog
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Moenkemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Breipohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Schueller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Schild
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. Golubnitschaja
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trog, D., Moenkemann, H., Breipohl, W. et al. Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions. Amino Acids 32, 373–379 (2007). https://doi.org/10.1007/s00726-006-0456-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-006-0456-1

Search

Navigation